InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: stoxx post# 273460

Tuesday, 09/27/2016 1:17:33 AM

Tuesday, September 27, 2016 1:17:33 AM

Post# of 345783
Every person knows someone that knows of another that has had some form of cancer or autoimmune disease and the value placed on this sort of extension of life is invaluable so can we honestly say what the pps of PPHM will land?

I will ask another question that one can use to justify a pps answer.... And that is to what extent did some try and block and run PS Targeting out of town ?? Many have heard of the puzzle pieces and abnormal control arms and unequal ECOG division and silent successes and DTRA and 12 week HepC etc etc and we can't forget Fargo sabotage like acts....etc etc so how much was all that trouble worth?

Peregrine can sell for $250 Billion for starters when all is said and done ... I say

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News